Neurofibromatosis type 2 in childhood: a clinical characterization

被引:1
|
作者
Hinojosa-Mateo, Carmen M. [1 ]
Reche-Sainz, Jose A. [2 ]
Hernandez-Nunez, Almudena [3 ]
Ramos-Lopez, Maria [4 ]
Arpa-Fernandez, Ana [5 ]
Natera-de Benito, Daniel [1 ]
机构
[1] Hosp Univ Fuenlabrada, Serv Pediat, Camino Molino 2, E-28942 Madrid, Spain
[2] Hosp Univ Fuenlabrada, Serv Oftalmol, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Serv Dermatol, Madrid, Spain
[4] Hosp Univ Fuenlabrada, Serv Radiol, Madrid, Spain
[5] Hosp Univ Fuenlabrada, Serv Lab Clin, Madrid, Spain
关键词
Childhood; Congenital cataract; Meningioma; Neurofibromatosis type 2; Schwannoma; Wishart; DIAGNOSIS; MANAGEMENT; NF2;
D O I
10.33588/rn.6403.2016355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Neurofibromatosis type 2 (NF2) is a dominantly inherited neuroectodermal syndrome that predispose to the development of tumors of the central and peripheral nervous system. Additional features include eye and skin abnormalities. Case report. A 12-year old male with diagnosis of MF2 according to Baser et al and presentation in childhood was included. A comprehensive bibliographic review of evolution of the diagnostic criteria for NF2 in children was performed. Conclusions. The pattern of presentation of NF2 in childhood differs from adulthood in many aspects. Ophthalmologic and skin manifestations, and not an auditory dysfunction, are the most common initial symptoms in prepuberal-onset NF2. The most frequent symptoms and signs at presentation are posterior subcapsular cataract, skin manifestations as NF2 plaques and/ or peripheral nerve tumors, and neurological dysfunction related to isolated or multiple cranial nerve deficits (other than nerve VIII), brainstem masses or spinal masses. As sensitivity of diagnostic criteria in children is low, those prepuberal patients with congenital or early-onset cataracts and typical skin manifestations of NF2 should be systematically assessed.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 50 条
  • [21] Neurofibromatosis type 2 (NF2): A clinical and molecular review
    Evans, D. Gareth R.
    ORPHANET JOURNAL OF RARE DISEASES, 2009, 4
  • [22] Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2
    Sperfeld, AD
    Hein, C
    Schröder, JM
    Ludolph, AC
    Hanemann, CO
    BRAIN, 2002, 125 : 996 - 1004
  • [23] Clinical and economic burden of neurofibromatosis type 2 in the United States
    Koo, Andrew B.
    Yeung, Jacky T.
    Freedman, Isaac G.
    Lee, Jun Hui
    Ahmed, Osama M.
    Ma, Anthony K.
    Miyagishima, Danielle F.
    DiLuna, Michael
    Kahle, Kristopher
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 197
  • [24] Neurofibromatosis type 2 in the elderly population: Clinical and molecular features
    Goutagny, Stephane
    Bah, Alpha B.
    Parfait, Beatrice
    Sterkers, Olivier
    Kalamarides, Michel
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161A (04) : 667 - 670
  • [25] Type 2 neurofibromatosis: Intergenerational differences in genetic and clinical expression
    Drouet, A.
    Le Moigne, F.
    Salame, D.
    Quesnel, L.
    Motolese, C.
    des Portes, V.
    Guilloton, L.
    Pinson, S.
    ARCHIVES DE PEDIATRIE, 2014, 21 (11): : 1233 - 1240
  • [26] Neurofibromatosis type 2. Clinical features and genetic profile
    Kluwe, L.
    Mautner, V-F.
    MEDIZINISCHE GENETIK, 2009, 21 (04) : 532 - 538
  • [27] Schwannomatosis: A clinical entity distinct from neurofibromatosis type 2
    Wolkenstein, P
    Benchikhi, H
    Zeller, J
    Wechsler, J
    Revuz, J
    DERMATOLOGY, 1997, 195 (03) : 228 - 231
  • [28] Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2
    Evans, D. Gareth
    Kalamarides, Michel
    Hunter-Schaedle, Kim
    Blakeley, Jaishri
    Allen, Jeffrey
    Babovic-Vuskanovic, Dusica
    Belzberg, Allan
    Bollag, Gideon
    Chen, Ruihong
    DiTomaso, Emmanuelle
    Golfinos, John
    Harris, Gordon
    Jacob, Abraham
    Kalpana, Ganjam
    Karajannis, Matthias
    Korf, Bruce
    Kurzrock, Razelle
    Law, Meng
    McClatchey, Andrea
    Packer, Roger
    Roehm, Pamela
    Rubenstein, Allan
    Slattery, William, III
    Tonsgard, James H.
    Welling, D. Bradley
    Widemann, Brigitte
    Yohay, Kaleb
    Giovannini, Marco
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5032 - 5039
  • [29] Clinical manifestations and genetic analysis of a family with neurofibromatosis type 2
    Wang, Victoria Y.
    Liu, Te-Yi
    Fang, Te-Yung
    Chen, Ya-Hui
    Huang, Chi-Jung
    Wang, Pa-Chun
    ACTA OTO-LARYNGOLOGICA, 2022, 142 (01) : 36 - 42
  • [30] Neurofibromatosis type 2
    Goutagny, S.
    Bouccara, D.
    Bozorg-Grayeli, A.
    Sterkers, O.
    Kalamarides, M.
    REVUE NEUROLOGIQUE, 2007, 163 (8-9) : 765 - 777